CVE-2023-6518: CWE-256 Plaintext Storage of a Password in Mia Technology Inc. MİA-MED
Plaintext Storage of a Password vulnerability in Mia Technology Inc. MİA-MED allows Read Sensitive Strings Within an Executable.This issue affects MİA-MED: before 1.0.7.
AI Analysis
Technical Summary
CVE-2023-6518 is a high-severity vulnerability identified in the MİA-MED software product developed by Mia Technology Inc. This vulnerability is categorized under CWE-256, which pertains to the plaintext storage of passwords. Specifically, the issue allows an attacker to read sensitive strings, including passwords, directly from the executable binary of MİA-MED versions prior to 1.0.7. Because the password is stored in plaintext within the executable, it can be extracted without requiring authentication or user interaction. The CVSS 3.1 base score of 7.5 reflects a high severity due to the vulnerability's network attack vector (AV:N), low attack complexity (AC:L), and no privileges or user interaction required (PR:N/UI:N). The impact is primarily on confidentiality, as an attacker can obtain sensitive credentials, potentially leading to unauthorized access to the system or connected resources. However, the vulnerability does not affect integrity or availability directly. No known exploits are currently reported in the wild, and no official patches have been linked yet, although the issue affects versions before 1.0.7, implying that later versions may have addressed the problem. The vulnerability was published on February 8, 2024, and is tracked by TR-CERT and CISA, indicating recognition by multiple cybersecurity authorities. The technical root cause is the insecure handling of password storage within the software, violating best practices for credential management and increasing the risk of credential theft and subsequent compromise.
Potential Impact
For European organizations using MİA-MED, this vulnerability poses a significant risk to the confidentiality of sensitive credentials embedded in the software. If exploited, attackers could extract plaintext passwords from the executable, potentially gaining unauthorized access to medical data or administrative functions within healthcare environments. Given the sensitivity of medical information and strict data protection regulations such as GDPR, unauthorized access could lead to severe privacy breaches, regulatory penalties, and reputational damage. Additionally, compromised credentials might be leveraged for lateral movement within networks, increasing the risk of broader system compromise. The lack of required authentication or user interaction for exploitation means that remote attackers can potentially automate attacks, increasing the threat surface. Although no active exploits are known, the high severity and ease of exploitation warrant immediate attention, especially in healthcare institutions where MİA-MED is deployed. The impact extends beyond confidentiality to potential compliance violations and operational disruptions if attackers misuse the credentials for further malicious activities.
Mitigation Recommendations
European organizations should prioritize upgrading MİA-MED to version 1.0.7 or later once available, as this likely contains fixes for the plaintext password storage issue. Until an official patch is released, organizations should implement compensating controls such as: 1) Restricting access to systems running vulnerable versions of MİA-MED to trusted personnel and networks only, minimizing exposure to remote attackers. 2) Employing application whitelisting and integrity monitoring to detect unauthorized modifications or attempts to extract executable contents. 3) Utilizing endpoint detection and response (EDR) solutions to monitor for suspicious activities related to credential extraction. 4) Conducting regular audits of credentials used within MİA-MED and rotating passwords frequently to limit the window of exposure. 5) Applying network segmentation to isolate medical devices and software from broader enterprise networks, reducing attack surface. 6) Educating IT and security teams about the vulnerability to ensure rapid response if suspicious activity is detected. 7) Considering additional encryption or obfuscation layers for sensitive data within the application environment if feasible. These measures, combined with prompt patching, will help mitigate the risk posed by this vulnerability.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Sweden
CVE-2023-6518: CWE-256 Plaintext Storage of a Password in Mia Technology Inc. MİA-MED
Description
Plaintext Storage of a Password vulnerability in Mia Technology Inc. MİA-MED allows Read Sensitive Strings Within an Executable.This issue affects MİA-MED: before 1.0.7.
AI-Powered Analysis
Technical Analysis
CVE-2023-6518 is a high-severity vulnerability identified in the MİA-MED software product developed by Mia Technology Inc. This vulnerability is categorized under CWE-256, which pertains to the plaintext storage of passwords. Specifically, the issue allows an attacker to read sensitive strings, including passwords, directly from the executable binary of MİA-MED versions prior to 1.0.7. Because the password is stored in plaintext within the executable, it can be extracted without requiring authentication or user interaction. The CVSS 3.1 base score of 7.5 reflects a high severity due to the vulnerability's network attack vector (AV:N), low attack complexity (AC:L), and no privileges or user interaction required (PR:N/UI:N). The impact is primarily on confidentiality, as an attacker can obtain sensitive credentials, potentially leading to unauthorized access to the system or connected resources. However, the vulnerability does not affect integrity or availability directly. No known exploits are currently reported in the wild, and no official patches have been linked yet, although the issue affects versions before 1.0.7, implying that later versions may have addressed the problem. The vulnerability was published on February 8, 2024, and is tracked by TR-CERT and CISA, indicating recognition by multiple cybersecurity authorities. The technical root cause is the insecure handling of password storage within the software, violating best practices for credential management and increasing the risk of credential theft and subsequent compromise.
Potential Impact
For European organizations using MİA-MED, this vulnerability poses a significant risk to the confidentiality of sensitive credentials embedded in the software. If exploited, attackers could extract plaintext passwords from the executable, potentially gaining unauthorized access to medical data or administrative functions within healthcare environments. Given the sensitivity of medical information and strict data protection regulations such as GDPR, unauthorized access could lead to severe privacy breaches, regulatory penalties, and reputational damage. Additionally, compromised credentials might be leveraged for lateral movement within networks, increasing the risk of broader system compromise. The lack of required authentication or user interaction for exploitation means that remote attackers can potentially automate attacks, increasing the threat surface. Although no active exploits are known, the high severity and ease of exploitation warrant immediate attention, especially in healthcare institutions where MİA-MED is deployed. The impact extends beyond confidentiality to potential compliance violations and operational disruptions if attackers misuse the credentials for further malicious activities.
Mitigation Recommendations
European organizations should prioritize upgrading MİA-MED to version 1.0.7 or later once available, as this likely contains fixes for the plaintext password storage issue. Until an official patch is released, organizations should implement compensating controls such as: 1) Restricting access to systems running vulnerable versions of MİA-MED to trusted personnel and networks only, minimizing exposure to remote attackers. 2) Employing application whitelisting and integrity monitoring to detect unauthorized modifications or attempts to extract executable contents. 3) Utilizing endpoint detection and response (EDR) solutions to monitor for suspicious activities related to credential extraction. 4) Conducting regular audits of credentials used within MİA-MED and rotating passwords frequently to limit the window of exposure. 5) Applying network segmentation to isolate medical devices and software from broader enterprise networks, reducing attack surface. 6) Educating IT and security teams about the vulnerability to ensure rapid response if suspicious activity is detected. 7) Considering additional encryption or obfuscation layers for sensitive data within the application environment if feasible. These measures, combined with prompt patching, will help mitigate the risk posed by this vulnerability.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- TR-CERT
- Date Reserved
- 2023-12-05T11:55:24.557Z
- Cisa Enriched
- true
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682cd0fa1484d88663aec3b4
Added to database: 5/20/2025, 6:59:06 PM
Last enriched: 7/4/2025, 7:10:08 PM
Last updated: 7/27/2025, 1:08:05 AM
Views: 12
Related Threats
CVE-2025-7679: CWE-306 Missing Authentication for Critical Function in ABB Aspect
HighCVE-2025-7677: CWE-306 Missing Authentication for Critical Function in ABB Aspect
MediumCVE-2025-53191: CWE-306 Missing Authentication for Critical Function in ABB Aspect
HighCVE-2025-53190: CWE-286 in ABB Aspect
HighCVE-2025-53189: CWE-639 Authorization Bypass Through User-Controlled Key in ABB Aspect
HighActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.